ACADIA PHARMACEUTICALS INC (ACAD)
DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP
DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP
Net Asset Value(s)
BOSS Zhipins Ongoing Share Repurchases Reach Over RMB1.99 Billion in 2026
Share Buy Back - Daily Share Buy-Back Notice: Share Buy Back - Daily Share Buy-Back Notice
Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy-Back Notice
Net Asset Value(s)
Share Buy Back - Daily Share Buy-Back Notice: Share Buy Back - Daily Share Buy-Back Notice
Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy Back Notice
Share Buy Back - Daily Share Buy-Back Notice: S$2Bn Value Realisation Share Buy-back Programme
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in Interest of Director